Ingrezza 40 MG capsule 30S
Ended Awarded
- Contract number
- SPE2DB25FQ0NB
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $3,676
Award facts
- Contract value 100% obligated
- $3,676.12 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of INGREZZA 40 mg capsules (30-count units) valued at $3,676.12 under a firm fixed price contract type. This non-set-aside award, issued on April 23, 2025, with an ultimate completion date of May 14, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX). AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs across military and veteran healthcare systems. INGREZZA is a prescription antipsychotic medication used in the treatment of neurological and psychiatric conditions, reflecting the company's role in supplying specialized pharmaceutical products to support DoD healthcare operations.
This delivery order is part of AmerisourceBergen's comprehensive $999.999 billion IDC with DLA extending through December 2026, which enables the company to supply an extensive range of pharmaceutical products, vaccines, medical devices, and specialized healthcare commodities globally. The award demonstrates AmerisourceBergen's continued capability to meet federal procurement requirements through competitive bidding and its significant position within the Defense Health Agency's pharmaceutical supply chain. As a prime vendor, AmerisourceBergen serves multiple federal healthcare customers, including the Defense Health Agency and U.S. Coast Guard, positioning the company as a critical supplier for military medical readiness and global healthcare support operations.
Quick answers
Who was awarded contract SPE2DB25FQ0NB?
SPE2DB25FQ0NB was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on April 23, 2025.
How much is contract SPE2DB25FQ0NB worth?
The government has obligated $3,676 on SPE2DB25FQ0NB.
Is contract SPE2DB25FQ0NB an order under another contract?
Yes. SPE2DB25FQ0NB is a delivery order under SPE2DB22D3011, an indefinite delivery contract.
Was contract SPE2DB25FQ0NB competed?
The extent of competition for SPE2DB25FQ0NB was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award